New insights into systemic sclerosis / / edited by Michal Tomcik.

Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic fe...

Full description

Saved in:
Bibliographic Details
:
TeilnehmendeR:
Place / Publishing House:London, United Kingdom : : IntechOpen,, [2019]
©2019
Year of Publication:2019
Language:English
Physical Description:1 online resource (160 pages) :; illustrations
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993544010404498
ctrlnum (CKB)4920000000094428
(NjHacI)994920000000094428
(oapen)https://directory.doabooks.org/handle/20.500.12854/54593
(EXLCZ)994920000000094428
collection bib_alma
record_format marc
spelling Michal Tomcik auth
New insights into systemic sclerosis / edited by Michal Tomcik.
IntechOpen 2019
London, United Kingdom : IntechOpen, [2019]
©2019
1 online resource (160 pages) : illustrations
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (InTech, viewed October 19, 2022).
Includes bibliographical references.
Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic feature that affects the skin and visceral organs. Life expectancy of scleroderma patients has improved over recent years, mainly because of better treatment of organ involvement and complications; however, no curative disease-modifying therapies exist to date. This book aims to provide students, trainees, rheumatologists, and other specialists interested in this disease with a comprehensive overview of novel pathogenetic mechanisms, management approaches, and therapeutic targets of several major vascular and fibrotic manifestations, and is useful insight into a number of usually neglected aspects of scleroderma.
English
Systemic scleroderma.
Medicine
Immunopathology
Immunology
Allergology and Rheumatology
Health Sciences
1-83962-204-0
Tomcik, Michal , editor.
language English
format eBook
author Michal Tomcik
spellingShingle Michal Tomcik
New insights into systemic sclerosis /
author_facet Michal Tomcik
Tomcik, Michal ,
author_variant m t mt
author2 Tomcik, Michal ,
author2_variant m t mt
author2_role TeilnehmendeR
author_sort Michal Tomcik
title New insights into systemic sclerosis /
title_full New insights into systemic sclerosis / edited by Michal Tomcik.
title_fullStr New insights into systemic sclerosis / edited by Michal Tomcik.
title_full_unstemmed New insights into systemic sclerosis / edited by Michal Tomcik.
title_auth New insights into systemic sclerosis /
title_new New insights into systemic sclerosis /
title_sort new insights into systemic sclerosis /
publisher IntechOpen
IntechOpen,
publishDate 2019
physical 1 online resource (160 pages) : illustrations
isbn 1-83962-206-7
1-83962-205-9
1-83962-204-0
callnumber-first R - Medicine
callnumber-subject RC - Internal Medicine
callnumber-label RC924
callnumber-sort RC 3924.5 S34 N49 42019
illustrated Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 616 - Diseases
dewey-full 616.544
dewey-sort 3616.544
dewey-raw 616.544
dewey-search 616.544
work_keys_str_mv AT michaltomcik newinsightsintosystemicsclerosis
AT tomcikmichal newinsightsintosystemicsclerosis
status_str n
ids_txt_mv (CKB)4920000000094428
(NjHacI)994920000000094428
(oapen)https://directory.doabooks.org/handle/20.500.12854/54593
(EXLCZ)994920000000094428
carrierType_str_mv cr
is_hierarchy_title New insights into systemic sclerosis /
author2_original_writing_str_mv noLinkedField
_version_ 1787548743305789440
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01062nam a2200313 i 4500</leader><controlfield tag="001">993544010404498</controlfield><controlfield tag="005">20221019220821.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221019s2019 enka ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83962-206-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83962-205-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094428</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000000094428</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/54593</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094428</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC924.5.S34</subfield><subfield code="b">.N49 2019</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.544</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Michal Tomcik</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">New insights into systemic sclerosis /</subfield><subfield code="c">edited by Michal Tomcik.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2019</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (160 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 19, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic feature that affects the skin and visceral organs. Life expectancy of scleroderma patients has improved over recent years, mainly because of better treatment of organ involvement and complications; however, no curative disease-modifying therapies exist to date. This book aims to provide students, trainees, rheumatologists, and other specialists interested in this disease with a comprehensive overview of novel pathogenetic mechanisms, management approaches, and therapeutic targets of several major vascular and fibrotic manifestations, and is useful insight into a number of usually neglected aspects of scleroderma.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Systemic scleroderma.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunopathology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Allergology and Rheumatology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83962-204-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomcik, Michal ,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 21:26:42 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5351662700004498&amp;Force_direct=true</subfield><subfield code="Z">5351662700004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351662700004498</subfield></datafield></record></collection>